BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people across the globe. Previous coronavirus outbreaks led to worsened symptoms amongst pregnant women, suggesting that pregnant women are at greater risk. OBJECTIVES: Our aim is to investigate the differences in clinical presentation, management, and prognosis of COVID-19 infection in pregnant and non-pregnant women. METHODS: We ran a search on electronic databases and analysis of the relevant articles was done using Revie Manager 5.4. RESULTS: The review consists of nine studies comprising 591,058 women (28,797 pregnant and 562,261 non-pregnant), with most of the data derived from two large studies. The risk of experiencing fever (RR: 0.74; 95% CI: 0.64-0.85), headache (RR: 0.77; 95% CI: 0.74-0.79), myalgia (RR: 0.92; 95% CI: 0.89-0.95), diarrhea (RR: 0.40, 95% CI: 0.39-0.43), chest tightness (RR: 0.86; 95% CI: 0.77-0.95), and expectoration (RR: 0.45; 95% CI: 0.21-0.97) were greater amongst non-pregnant COVID-19-infected women. Pregnant women with COVID-19 were less likely to be obese (RR: 0.68; 95% CI: 0.63-0.73) or have a smoking history (RR: 0.32; 95% CI: 0.26-0.39). COVID-19-infected non-pregnant women had a higher frequency of comorbidity such as chronic cardiac disease (RR: 0.58; 95% CI: 0.44-0.77), renal disease (RR: 0.45; 95% CI: 0.29-0.71), and malignancy (RR: 0.82; 95% CI: 0.68-0.98), compared to COVID-19-infected pregnant women. The risk of ICU admission (RR: 2.26; 95% CI: 1.68-3.05) and requirement of invasive mechanical ventilation (RR: 2.68; 95% CI: 2.07-3.47) were significantly higher amongst pregnant women. CONCLUSIONS: Although the frequency of risk factors and the risk of experiencing clinical symptoms of COVID-19 were higher among non-pregnant women, COVID-19-infected pregnant women had a higher requirement of ICU admission and invasive mechanical ventilation compared to non-pregnant COVID-19-infected women. More well-conducted studies from varying contexts are needed to draw conclusions. Prospero registration: CRD42020204638.
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people across the globe. Previous coronavirus outbreaks led to worsened symptoms amongst pregnant women, suggesting that pregnant women are at greater risk. OBJECTIVES: Our aim is to investigate the differences in clinical presentation, management, and prognosis of COVID-19infection in pregnant and non-pregnant women. METHODS: We ran a search on electronic databases and analysis of the relevant articles was done using Revie Manager 5.4. RESULTS: The review consists of nine studies comprising 591,058 women (28,797 pregnant and 562,261 non-pregnant), with most of the data derived from two large studies. The risk of experiencing fever (RR: 0.74; 95% CI: 0.64-0.85), headache (RR: 0.77; 95% CI: 0.74-0.79), myalgia (RR: 0.92; 95% CI: 0.89-0.95), diarrhea (RR: 0.40, 95% CI: 0.39-0.43), chest tightness (RR: 0.86; 95% CI: 0.77-0.95), and expectoration (RR: 0.45; 95% CI: 0.21-0.97) were greater amongst non-pregnant COVID-19-infectedwomen. Pregnant women with COVID-19 were less likely to be obese (RR: 0.68; 95% CI: 0.63-0.73) or have a smoking history (RR: 0.32; 95% CI: 0.26-0.39). COVID-19-infected non-pregnant women had a higher frequency of comorbidity such as chronic cardiac disease (RR: 0.58; 95% CI: 0.44-0.77), renal disease (RR: 0.45; 95% CI: 0.29-0.71), and malignancy (RR: 0.82; 95% CI: 0.68-0.98), compared to COVID-19-infected pregnant women. The risk of ICU admission (RR: 2.26; 95% CI: 1.68-3.05) and requirement of invasive mechanical ventilation (RR: 2.68; 95% CI: 2.07-3.47) were significantly higher amongst pregnant women. CONCLUSIONS: Although the frequency of risk factors and the risk of experiencing clinical symptoms of COVID-19 were higher among non-pregnant women, COVID-19-infected pregnant women had a higher requirement of ICU admission and invasive mechanical ventilation compared to non-pregnant COVID-19-infectedwomen. More well-conducted studies from varying contexts are needed to draw conclusions. Prospero registration: CRD42020204638.
Authors: Yusuke Matsui; Lin Li; Mary Prahl; Arianna G Cassidy; Nida Ozarslan; Yarden Golan; Veronica J Gonzalez; Christine Y Lin; Unurzul Jigmeddagva; Megan A Chidboy; Mauricio Montano; Taha Y Taha; Mir M Khalid; Bharath Sreekumar; Jennifer M Hayashi; Pei-Yi Chen; G Renuka Kumar; Lakshmi Warrier; Alan Hb Wu; Dongli Song; Priya Jegatheesan; Daljeet S Rai; Balaji Govindaswami; Jordan Needens; Monica Rincon; Leslie Myatt; Ifeyinwa V Asiodu; Valerie J Flaherman; Yalda Afshar; Vanessa L Jacoby; Amy P Murtha; Joshua F Robinson; Melanie Ott; Warner C Greene; Stephanie L Gaw Journal: JCI Insight Date: 2022-06-22
Authors: Caroline G Atyeo; Lydia L Shook; Sara Brigida; Rose M De Guzman; Stepan Demidkin; Cordelia Muir; Babatunde Akinwunmi; Arantxa Medina Baez; Maegan L Sheehan; Erin McSweeney; Madeleine D Burns; Ruhi Nayak; Maya K Kumar; Chinmay D Patel; Allison Fialkowski; Dana Cvrk; Ilona T Goldfarb; Lael M Yonker; Alessio Fasano; Alejandro B Balazs; Michal A Elovitz; Kathryn J Gray; Galit Alter; Andrea G Edlow Journal: Nat Commun Date: 2022-06-28 Impact factor: 17.694
Authors: Renato T Souza; Jose G Cecatti; Rodolfo C Pacagnella; Carolina C Ribeiro-Do-Valle; Adriana G Luz; Giuliane J Lajos; Guilherme M Nobrega; Thayna B Griggio; Charles M Charles; Silvana F Bento; Carla Silveira; Fernanda G Surita; Maria J Miele; Ricardo P Tedesco; Karayna G Fernandes; Sérgio H A Martins-Costa; Frederico J A Peret; Francisco E Feitosa; Rosiane Mattar; Evelyn Traina; Edson V Cunha Filho; Janete Vettorazzi; Samira M Haddad; Carla B Andreucci; José P Guida; Mario D Correa Junior; Marcos A B Dias; Leandro De Oliveira; Elias F Melo Junior; Marília G Q Luz; Maria Laura Costa Journal: Sci Rep Date: 2022-07-11 Impact factor: 4.996
Authors: Mei H Chang; Kelsie Cowman; Yi Guo; Hongkai Bao; Peter S Bernstein; Inessa Gendlina; Priya Nori Journal: Am J Obstet Gynecol Date: 2022-01-21 Impact factor: 10.693
Authors: Rupsa C Boelig; Kjersti M Aagaard; Michelle P Debbink; Alireza A Shamshirsaz Journal: Am J Obstet Gynecol Date: 2021-09-03 Impact factor: 8.661